Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells

Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells

BackgroundPatients with muscle-invasive bladder cancer face a poor prognosis due to rapid disease progression and chemoresistance. Thus, there is an urgent need for a new therapeutic treatment. The tumor microenvironment (TME) has crucial roles in tumor development, growth, progression, and therapy...

Full description

Bibliographic Details
Main Authors:	Lucie M. Frerichs, Bastian Frerichs, Patrick Petzsch, Karl Köhrer, Joachim Windolf, Bernd Bittersohl, Michèle J. Hoffmann, Vera Grotheer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Oncology
Subjects:	tumor microenvironment bladder cancer mesenchymal stem cells fibroblasts cisplatin resistance CD44
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1228185/full

Similar Items

Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1
by: Chenyin Wang, et al.
Published: (2020-02-01)

TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells
by: Qinrong Ping, et al.
Published: (2023-07-01)

Paracrine Signaling from a Three-Dimensional Model of Bladder Carcinoma and from Normal Bladder Switch the Phenotype of Stromal Fibroblasts
by: Sandra Camargo, et al.
Published: (2021-06-01)

MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
by: Tibor Szarvas, et al.
Published: (2020-12-01)

Bisphenol A Alters the Energy Metabolism of Stromal Cells and Could Promote Bladder Cancer Progression
by: Ève Pellerin, et al.
Published: (2021-10-01)

Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro
by: Natália V. Segatto, et al.
Published: (2024-02-01)

Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
by: Raisa A. Glabman, et al.
Published: (2022-08-01)

The role of cancer-associated fibroblasts in bladder cancer progression
by: Long Huang, et al.
Published: (2023-09-01)

Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity
by: Lijie Wen, et al.
Published: (2020-04-01)

Author Correction: Osteogenic differentiation of human mesenchymal stromal cells and fibroblasts differs depending on tissue origin and replicative senescence
by: Vera Grotheer, et al.
Published: (2021-08-01)

Author Correction: Osteogenic differentiation of human mesenchymal stromal cells and fibroblasts differs depending on tissue origin and replicative senescence
by: Vera Grotheer, et al.
Published: (2021-07-01)

A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer
by: Amy Burley, et al.
Published: (2022-10-01)

Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells
by: Lin JF, et al.
Published: (2017-05-01)

The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells
by: Michael Rose, et al.
Published: (2021-04-01)

CD44 in Bladder Cancer
by: Jason Duex, et al.
Published: (2024-03-01)

Osteogenic differentiation of human mesenchymal stromal cells and fibroblasts differs depending on tissue origin and replicative senescence
by: Vera Grotheer, et al.
Published: (2021-06-01)

An HGF‐dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis
by: Yuting Li, et al.
Published: (2023-12-01)

Integrated single‐cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial–fibroblast interactions in recurrent bladder cancer
by: Zhen‐Duo Shi, et al.
Published: (2023-07-01)

Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro
by: Saira Justin, et al.
Published: (2020-08-01)

Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma
by: Yiwei Gu, et al.
Published: (2023-12-01)

Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression
by: YiHeng Du, et al.
Published: (2021-11-01)

Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis
by: Lanpeng Lu, et al.
Published: (2023-11-01)

A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment
by: Anna Tosi, et al.
Published: (2024-04-01)

Anticancer properties of cannabidiol and Δ9-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines
by: Erin G. Whynot, et al.
Published: (2023-03-01)

Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor
by: Hirofumi Yoshino, et al.
Published: (2023-06-01)

A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro
by: Yujin Chen, et al.
Published: (2018-05-01)

Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction
by: Fuguang Zhao, et al.
Published: (2020-12-01)

Cancer‐Associated Fibroblast‐Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer
by: Ting Liang, et al.
Published: (2023-11-01)

GALC Triggers Tumorigenicity of Colorectal Cancer via Senescent Fibroblasts
by: Mengdi Yang, et al.
Published: (2020-04-01)

A ‘golden’ alternative for prevention of cisplatin nephrotoxicity in bladder cancer
by: Yoray Sharon, et al.
Published: (2023-09-01)

Self-polymerized platinum (II)-Polydopamine nanomedicines for photo-chemotherapy of bladder Cancer favoring antitumor immune responses
by: Ren Mo, et al.
Published: (2023-07-01)

Fascin Inhibitors Decrease Cell Migration and Adhesion While Increase Overall Survival of Mice Bearing Bladder Cancers
by: Zhankui Zhao, et al.
Published: (2021-05-01)

Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature
by: Wenhao Wang, et al.
Published: (2022-12-01)

The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer
by: YiHeng Du, et al.
Published: (2021-05-01)

Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer
by: Meng Zhang, et al.
Published: (2023-06-01)

Cluster of differentiation 44 and matrix metalloproteinase 2 markers: A prospective study and insight to their role in bladder cancer
by: Manoj Yadav, et al.
Published: (2023-01-01)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
by: Csilla Olah, et al.
Published: (2023-03-01)

Clinical Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy on Muscle-invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2019-04-01)

Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect
by: Julieta Afonso, et al.
Published: (2024-04-01)

Human esophageal fibroblast-derived exosomal miR-21 reduced the cisplatin sensitivity to esophageal carcinoma EC9706 cells
by: Jiajin Wan, et al.
Published: (2021-08-01)